Carmignac Gestion Regenxbio Inc. Transaction History

Carmignac Gestion

$5.82 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$24.62 - $34.31 $1.14 Million - $1.59 Million	-46,369 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$30.19 - $40.28 $3.85 Million - $5.13 Million	-127,471 Reduced 73.33%	46,369 $1.52 Million
Q3 2021 Nov 12, 2021	SELL	$29.09 - $45.68 $369,413 - $580,090	-12,699 Reduced 6.81%	173,840 $7.29 Million
Q2 2021 Aug 13, 2021	SELL	$32.46 - $40.48 $2.16 Million - $2.69 Million	-66,463 Reduced 26.27%	186,539 $7.25 Million
Q1 2021 May 14, 2021	BUY	$33.61 - $49.95 $5.6 Million - $8.32 Million	166,600 Added 192.82%	253,002 $8.63 Million
Q4 2020 Feb 12, 2021	SELL	$26.52 - $49.35 $1.58 Million - $2.94 Million	-59,626 Reduced 40.83%	86,402 $3.92 Million
Q3 2020 Nov 13, 2020	SELL	$27.01 - $40.26 $733,699 - $1.09 Million	-27,164 Reduced 15.68%	146,028 $4.02 Million
Q2 2020 Aug 13, 2020	BUY	$27.75 - $43.44 $118,964 - $186,227	4,287 Added 2.54%	173,192 $6.38 Million
Q1 2020 May 14, 2020	SELL	$21.5 - $54.2 $2.59 Million - $6.52 Million	-120,376 Reduced 41.61%	168,905 $5.47 Million
Q4 2019 Feb 13, 2020	SELL	$34.54 - $44.87 $33 Million - $42.8 Million	-954,440 Reduced 76.74%	289,281 $11.9 Million
Q3 2019 Nov 13, 2019	SELL	$31.84 - $50.88 $4.41 Million - $7.05 Million	-138,541 Reduced 10.02%	1,243,721 $44.3 Million
Q2 2019 Aug 13, 2019	BUY	$42.0 - $59.29 $31.2 Million - $44.1 Million	743,067 Added 116.25%	1,382,262 $71 Million
Q1 2019 May 14, 2019	BUY	$40.82 - $62.45 $19.1 Million - $29.2 Million	467,869 Added 273.09%	639,195 $36.6 Million
Q4 2018 Feb 13, 2019	BUY	$39.11 - $75.15 $2.35 Million - $4.51 Million	60,020 Added 53.92%	171,326 $7.19 Million
Q3 2018 Nov 13, 2018	BUY	$65.0 - $82.15 $2.16 Million - $2.74 Million	33,305 Added 42.7%	111,306 $8.4 Million
Q2 2018 Aug 13, 2018	BUY	$27.2 - $74.35 $2.12 Million - $5.8 Million	78,001 New	78,001 $5.6 Million

Others Institutions Holding RGNX

# of Institutions

190

Shares Held

43.2M

Call Options Held

104K

Put Options Held

478K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $325M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Carmignac Gestion, based on Form 13F filings with the SEC.

News

Stay updated on Carmignac Gestion with notifications on news.

Account